# A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

> **NCT01186770** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 804 (actual)

## Conditions studied

- Opioid-Induced Constipation

## Interventions

- **DRUG:** Methylnaltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01186770
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-01
- **Primary completion:** 2011-09-08
- **Final completion:** 2011-09-08
- **Target enrollment:** 804 (ACTUAL)
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186770, "A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01186770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*